P62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Cha Molstad, Hyunjoo ^a   Yu, Ji Eun ^a,b   Feng, Zhiwei ^c,d   Lee, Su Hyun ^e   Kim, Jung Gi ^a,f   Yang, Peng ^c,d   Han, Bitnara ^g   Sung, Ki Woon ^e   Yoo, Young Dong ^e   Hwang, Joonsung ^a   McGuire, Terry ^c,d   Shim, Sang Mi ^e   Song, Hyun Dong ^h   Ganipisetti, Srinivasrao ^a   Wang, Nuozhou ^c,d   Jang, Jun Min ^e,j   Lee, Min Jae ^h   Kim, Seung Jun ^a   Lee, Kyung Ho ^a   Hong, Jin Tae ^b   Ciechanover, Aaron ^e,i   Mook Jung, Inhee ^h   Kim, Kwang Pyo ^g   Xie, Xiang Qun ^c,d   Kwon, Yong Tae ^e   Kim, Bo Yeon ^a,f   more..

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungbuk National University   (South Korea)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Seoul National University   (South Korea)

^f University of Science and Technology (UST)   (South Korea)

^g Kyung Hee University   (South Korea)

^h Seoul National University College of Medicine   (South Korea)

ⁱ TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^j Quality Control Team   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BINDING PROTEIN; HUNTINGTIN; N RECOGNIN; SEQUESTOSOME 1; UNCLASSIFIED DRUG; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; PROTEASOME; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UBR1 PROTEIN, MOUSE;

AGGREGATION; AMINO ACID; CELLS AND CELL COMPONENTS; CHEMICAL BINDING; DEGRADATION; LIGAND; PHYSIOLOGY; PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; BIOGENESIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISULFIDE BOND; GEL ELECTROPHORESIS; HEK293 CELL LINE; HYDROGEN BOND; IMMUNOPRECIPITATION; IN VITRO STUDY; MACROAUTOPHAGY; METABOLIC STABILITY; N TERMINAL DEGRON; POINT MUTATION; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SELECTIVE AUTOPHAGY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; UBIQUITINATION; ULTRACENTRIFUGATION; ANIMAL; AUTOPHAGY; BINDING SITE; CELL CULTURE; CHEMISTRY; CONFOCAL MICROSCOPY; GENETICS; HELA CELL LINE; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOLECULAR MODEL; PROTEIN DEGRADATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ARGININE; AUTOPHAGOSOMES; AUTOPHAGY; BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; HEK293 CELLS; HELA CELLS; HUMANS; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, MOLECULAR; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN DOMAINS; PROTEOLYSIS; SEQUESTOSOME-1 PROTEIN; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 85025816140     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-00085-7     Document Type: Article

References (69)

1. Rubinsztein, D. C. The roles of intracellular protein degradation pathways in neurodegeneration. Nature 443, 780-786 (2006).
2. Komatsu, M. et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy deficient mice. Cell 131, 1149-1163 (2007).
3. Iwata, J. et al. Excess peroxisomes are degraded by autophagic machinery in mammals. J. Biol. Chem. 281, 4035-4041 (2006).
4. Orvedahl, A. et al. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 7, 115-127 (2010).
5. Yoshikawa, Y. et al. Listeria monocytogenes ActA-mediated escape from autophagic recognition. Nat. Cell Biol. 11, 1233-1240 (2009).
6. Schubert, U. et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404, 770-774 (2000).
7. Kopito, R. R. et al. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10, 524-530 (2000).
8. Williams, A. et al. Novel targets for Huntington's disease in an mTORindependent autophagy pathway. Nat. Chem. Biol. 4, 295-305 (2008).
9. Ciechanover, A. & Kwon, Y. T. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp. Mol. Med. 47, e147 (2015).
10. Ding, W. X. et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am. J. Pathol. 171, 513-524 (2007).
11. Cha-Molstad, H. et al. Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding. Nat. Cell Biol. 17, 917-929 (2015).
12. Rogov, V., Dotsch, V., Johansen, T. & Kirkin, V. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol. Cell 53, 167-178 (2014).
13. Korolchuk, V. I., Menzies, F. M. & Rubinsztein, D. C. Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett. 584, 1393-1398 (2010).
14. Milani, M. et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res. 69, 4415-4423 (2009).
15. Moscat, J. & Diaz-Meco, M. T. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137, 1001-1004 (2009).
16. Lu, K., Psakhye, I. & Jentsch, S. Autophagic clearance of polyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family. Cell 158, 549-563 (2014).
17. Bachmair, A., Finley, D. & Varshavsky, A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234, 179-186 (1986).
18. Sriram, S. M. & Kwon, Y. T. The molecular principles of N-end rule recognition. Nat. Struct. Mol. Biol. 17, 1164-1165 (2010).
19. Sriram, S. M., Kim, B. Y. & Kwon, Y. T. The N-end rule pathway: emerging functions and molecular principles of substrate recognition. Nat. Rev. Mol. Cell Biol. 12, 735-747 (2011).
20. Tasaki, T. et al. UBR box N-recognin-4 (UBR4), an N-recognin of the N-end rule pathway, and its role in yolk sac vascular development and autophagy. Proc. Natl. Acad. Sci. USA. 110, 3800-3805 (2013).
21. Tyers, M. & Jorgensen, P. Proteolysis and the cell cycle: with this RING I do thee destroy. Curr. Opin. Genet. Dev. 10, 54-64 (2000).
22. Kamura, T. et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284, 657-661 (1999).
23. An, J. Y. et al. UBR2 of the N-end rule pathway is required for chromosome stability via histone ubiquitylation in spermatocytes and somatic cells. PLoS ONE 7, e37414 (2012).
24. Sriram, S. M., Banerjee, R., Kane, R. S. & Kwon, Y. T. Multivalency-assisted control of intracellular signaling pathways: application for ubiquitin-dependent N-end rule pathway. Chem. Biol. 16, 121-131 (2009).
25. Lee, M. J. et al. Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway. Proc. Natl. Acad. Sci. USA 105, 100-105 (2008).
26. Tasaki, T., Sriram, S. M., Park, K. S. & Kwon, Y. T. The N-end rule pathway. Annu. Rev. Biochem. 81, 261-289 (2012).
27. Kwon, Y. T., Kashina, A. S. & Varshavsky, A. Alternative splicing results in differential expression, activity, and localization of the two forms of arginyl-tRNA-protein transferase, a component of the N-end rule pathway. Mol. Cell Biol. 19, 182-193 (1999).
28. Kwon, Y. T. et al. An essential role of N-terminal arginylation in cardiovascular development. Science 297, 96-99 (2002).
29. Lee, M. J. et al. RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. Proc. Natl. Acad. Sci. USA 102, 15030-15035 (2005).
30. Kwon, Y. T. et al. The mouse and human genes encoding the recognition component of the N-end rule pathway. Proc. Natl. Acad. Sci. USA 95, 7898-7903 (1998).
31. Kwon, Y. T., Xia, Z., Davydov, I. V., Lecker, S. H. & Varshavsky, A. Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1 (E3alpha) of the N-end rule pathway. Mol. Cell. Biol. 21, 8007-8021 (2001).
32. Kwon, Y. T. et al. Female lethality and apoptosis of spermatocytes in mice lacking the UBR2 ubiquitin ligase of the N-end rule pathway. Mol. Cell. Biol. 23, 8255-8271 (2003).
33. Lee, M. J. et al. Characterization of arginylation branch of N-end rule pathway in G-protein-mediated proliferation and signaling of cardiomyocytes. J. Biol. Chem. 287, 24043-24052 (2012).
34. Tasaki, T. & Kwon, Y. T. The mammalian N-end rule pathway: new insights into its components and physiological roles. Trends Biochem. Sci. 32, 520-528 (2007).
35. Tasaki, T. et al. The substrate recognition domains of the N-end rule pathway. J. Biol. Chem. 284, 1884-1895 (2009).
36. Kwon, Y. T., Lévy, F. & Varshavsky, A. Bivalent inhibitor of the N-end rule pathway. J. Biol. Chem. 274, 18135-18139 (1999).
37. Balogh, S. A., Kwon, Y. T. & Denenberg, V. H. Varying intertrial interval reveals temporally defined memory deficits and enhancements in NTAN1-deficient mice. Learn. Mem. 7, 279-286 (2000).
38. Piatkov, K. I., Oh, J. H., Liu, Y. & Varshavsky, A. Calpain-generated natural protein fragments as short-lived substrates of the N-end rule pathway. Proc. Natl. Acad. Sci. USA 111, E817-826 (2014).
39. Brower, C. S., Piatkov, K. I. & Varshavsky, A. Neurodegeneration-associated protein fragments as short-lived substrates of the N-end rule pathway. Mol. Cell 50, 161-171 (2013).
40. Piatkov, K. I., Brower, C. S. & Varshavsky, A. The N-end rule pathway counteracts cell death by destroying proapoptotic protein fragments. Proc. Natl. Acad. Sci. USA 109, E1839-1847 (2012).
41. Seibenhener, M. L. et al. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol. Cell. Biol. 24, 8055-8068 (2004).
42. Xia, Z. et al. Substrate-binding sites of UBR1, the ubiquitin ligase of the N-end rule pathway. J. Biol. Chem. 283, 24011-24028 (2008).
43. Choi, W. S. et al. Structural basis for the recognition of N-end rule substrates by the UBR box of ubiquitin ligases. Nat. Struct. Mol. Biol. 17, 1175-1181 (2010).
44. Matta-Camacho, E., Kozlov, G., Li, F. F. & Gehring, K. Structural basis of substrate recognition and specificity in the N-end rule pathway. Nat. Struct. Mol. Biol. 17, 1182-1187 (2010).
45. Moscat, J., Diaz-Meco, M. T., Albert, A. & Campuzano, S. Cell signaling and function organized by PB1 domain interactions. Mol. Cell 23, 631-640 (2006).
46. Rusten, T. E. & Stenmark, H. p62, an autophagy hero or culprit? Nat. Cell Biol. 12, 207-209 (2010).
47. Martí-Renom, M. A. et al. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29, 291-325 (2000).
48. Xie, X. Q. & Chen, J. Data-mining a small molecule drug screening representative subset from PubChem database. J. Chem. Inf. Model. 48, 465-475 (2008).
49. Itakura, E. & Mizushima, N. p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J. Cell Biol. 192, 17-27 (2011).
50. Jin, M., Liu, X. & Klionsky, D. J. SnapShot: selective autophagy. Cell 152, 368-368 (2013).
51. Hannah, C. D. et al. WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1. Mol. Cell 55, 238-252 (2014).
52. Gelman, A., Rawet-Slobodkin, M. & Elazar, Z. Huntingtin facilitates selective autophagy. Nat. Cell Biol. 17, 214-215 (2015).
53. Pandey, U. B. et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863 (2007).
54. Gamerdinger, M. et al. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 28, 889-901 (2009).
55. Donohue, E., Balgi, A. D., Komatsu, M. & Roberge, M. Induction of covalently crosslinked p62 oligomers with reduced binding to polyubiquitinated proteins by the autophagy inhibitor verteporfin. PLoS ONE 9, e114964 (2014).
56. Matsumoto, G., Wada, K., Okuno, M., Kurosawa, M. & Nukina, N. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol. Cell 44, 279-289 (2011).
57. Ichimura, Y. et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 51, 618-631 (2013).
58. Høyer-Hansen, M. & Jäättelä, M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 14, 1576-1582 (2007).
59. Du, Y. et al. An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity. Autophagy 5, 663-675 (2009).
60. Vousden, K. H. & Ryan, K. M. p53 and metabolism. Nat. Rev. Cancer 9, 691-700 (2009).
61. Caccamo, A., Majumder, S., Richardson, A., Strong, R. & Oddo, S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107-13120 (2010).
62. Sarkar, S. & Rubinsztein, D. C. Huntington's disease: degradation of mutant huntingtin by autophagy. FEBS J. 275, 4263-4270 (2008).
63. Chen, J. Z., Wang, J. & Xie, X. Q. GPCR structure-based virtual screening approach for CB2 antagonist search. J. Chem. Inf. Model. 47, 1626-1637 (2007).
64. Xie, X. Q., Chen, J. Z. & Billings, E. M. 3D structural model of the G-proteincoupled cannabinoid CB2 receptor. Proteins 53, 307-319 (2003).
65. Gertsch, J. et al. Beta-caryophyllene is a dietary cannabinoid. Proc. Natl. Acad. Sci. USA 105, 9099-9104 (2008).
66. Xie, X. Q. & Chowdhury, A. Advances in methods to characterize ligandinduced ionic lock and rotamer toggle molecular switch in G protein-coupled receptors. Methods Enzymol. 520, 153-174 (2013).
67. Yang, P. et al. Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitors. J. Med. Chem. 55, 9973-9987 (2012).
68. Gao, Y. et al. Small-molecule inhibitors targeting INK4 protein p18(INK4C) enhance ex vivo expansion of haematopoietic stem cells. Nat. Commun. 6, 6328 (2015).
69. Fiala, G. J., Schamel, W. W. & Blumenthal, B. Blue native polyacrylamide gel electrophoresis (BN-PAGE) for analysis of multiprotein complexes from cellular lysates. J. Vis. Exp. 24, 2164 (2011).